Merge revenues grow during second quarterConnectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts’ expectations, according to the company. The Milwaukee, WI-based vendor
Connectivity and PACS firm Merge Technologies reported preliminary results for its second quarter that will be below analysts expectations, according to the company. The Milwaukee, WI-based vendor expects revenue to be approximately $2.8 million, a 47% increase compared with the $1.9 million reported in the same period last year. Merge anticipates a net loss of 8 cents to 11 cents a share for the quarter (end-June). The company had a net loss of 12 cents per share in the same period in 1998.
In other Merge news, the company has installed its 275th MergeWorks DICOM clinical imaging network in the U.S. Merge began shipping MergeWorks in the U.S. in 1996. Earlier this year, Merge began offering MergeWorks in Europe, and the company has installed networks at five European sites. In the second quarter, the firms systems solutions division posted a 70% increase in revenue compared with the same period in 1998.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.